Successful treatment of three severe MDR or XDR Pseudomonas aeruginosa infections with ceftolozane/tazobactam.

about

Successful treatment of three severe MDR or XDR Pseudomonas aeruginosa infections with ceftolozane/tazobactam.

Item

http://www.wikidata.org/entity/Q41990882

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Successful treatment of three ...... s with ceftolozane/tazobactam.

@en

type

Item

label

Successful treatment of three ...... s with ceftolozane/tazobactam.

@en

prefLabel

Successful treatment of three ...... s with ceftolozane/tazobactam.

@en

P1476

Successful treatment of three ...... s with ceftolozane/tazobactam.

@en

P2093

Alex Soriano

http://www.w3.org/2001/XMLSchema#string

José A Martínez

http://www.w3.org/2001/XMLSchema#string

Marc Xipell

http://www.w3.org/2001/XMLSchema#string

Marta Bodro

http://www.w3.org/2001/XMLSchema#string

P2860

Healthcare-associated infections, infection control and the potential of new antibiotics in development in the USA

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model

Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia.

Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations

Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections.

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15).

Successful treatment of multidrug-resistant Pseudomonas aeruginosa breakthrough bacteremia with ceftolozane/tazobactam.

Characteristics and Outcomes of Complicated Intra-abdominal Infections Involving Pseudomonas aeruginosa from a Randomized, Double-Blind, Phase 3 Ceftolozane-Tazobactam Study.

Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates.

P304

1323-1326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FMB-2017-0018

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francesc Marco

P577

2017-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28980834

http://www.w3.org/2001/XMLSchema#string

P921

ceftolozane